France· FR:65574434
RIAMET 20 mg/120 mg, comprimé
A medicinal product containing luméfantrine + artéméther, registered in France by NOVARTIS PHARMA, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- LUMÉFANTRINE + ARTÉMÉTHER
- Manufacturer
- NOVARTIS PHARMA
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip1334009276033034 plaquette(s) PVC polyéthylène PVDC aluminium de 6 comprimé(s)EUR 33.19
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Luméfantrine + artéméther in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandRiamet 20 mg/120 mg, TablettenNovartis Pharma Schweiz AG
- GermanyRiametNovartis Pharma Gmbh
- SpainRIAMET 20 mg/120 mg COMPRIMIDOSNovartis Farmaceutica S.A.
- FinlandRiametNovartis Finland Oy
- United KingdomRiamet tabletsNovartis Pharmaceuticals UK Ltd
- NetherlandsRiamet 20 mg/120 mg, tablettenNovartis Pharma B.V.
- NorwayRiametNovartis (2)
- SwedenRiamet 20 mg/120 mg TablettNovartis Sverige AB
Authorised across Europe · EMA
The same active substance is authorised in 7 EEA countries. Names it is sold under:
- Austria · Riamet
- Belgium · Riamet
- Germany · Riamet
- United Kingdom (Northern Ireland) · Riamet
- Netherlands · Riamet
- Portugal · Airalam, Artemeter + Lumefantrina Phagecon
- Sweden · Riamet
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/797c8ef5-7b34-44eb-ab9d-c5f6ff0dd2e4 GET /v1/drugs/797c8ef5-7b34-44eb-ab9d-c5f6ff0dd2e4?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "65574434",
"date_amm": "2001-04-23",
"type_amm": "Procédure de reconnaissance mutuelle",
"numero_ue": null,
"substance": "LUMÉFANTRINE + ARTÉMÉTHER",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about luméfantrine + artéméther.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.